Well Told Grants

Federal grant recipients / New York

Federal grants to Chimerna Therapeutics, Inc.

New York, New York · Small businesses · UEI JMH6UEKMAE65

Chimerna Therapeutics, Inc. in New York, New York received $2.6 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Biomedical Research and Research Training, with $1.8 million. In fiscal 2025 it was awarded $302,605.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Chimerna Therapeutics, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20210$0
FY 20223$1.1 million
FY 20231$600,998
FY 20242$608,668
FY 20251$302,605

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Chimerna Therapeutics, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Biomedical Research and Research Training 93.8592$1.8 million
National Center for Advancing Translational Sciences 93.3501$297,608
Extramural Research Programs in the Neurosciences and Neurological Disorders 93.8531$256,158
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8471$255,236

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services5$2.6 million

Largest awards

The 5 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Next-generation rna synthesis and labeling kits - summary: circular rnas are an important class of rnas that have fundamental cellular functions and have the potential to be novel types of rna-based therapeutics. Circular rnas are difficult to synthesize and purify due to low yields after gel extrac
ASST_NON_R44GM139433_075 on USAspending
Biomedical Research and Research TrainingAugust 30, 2022$1.5 million
Synthetic biology approaches for bio-orthogonal labeling of circular rnas - summary the key challenges for rna therapeutics are delivery and stability inside of cells. Circular rnas that lack a 5’ and 3’ end are resistant to intracellular degradation, which allows them to persist for much longer tha
ASST_NON_R43GM157885_075 on USAspending
Biomedical Research and Research TrainingJanuary 22, 2025$302,605
Development of circrna manufacturing platform in yeast - summary: circular rnas (circrnas) are a novel class of rnas that hold immense potential as therapeutics due to their unique cellular functions. However, the challenges associated with their synthesis and purification have impeded their researc
ASST_NON_R43TR004890_075 on USAspending
National Center for Advancing Translational SciencesDecember 20, 2023$297,608
A novel TDP-43-TARGETING circular rna to treat amyotrophic lateral sclerosis (ALS) - summary amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by inclusion bodies containing the TDP-43 protein in the cytoplasm of motor neurons. These inclusion bodies are caused b
ASST_NON_R43NS129441_075 on USAspending
Extramural Research Programs in the Neurosciences and Neurological DisordersSeptember 7, 2022$256,158
Circular rna aptamers to regulate iron homeostasis in iron overload disorders - summary: iron overload disorders are caused by homeostatic imbalance of iron in the liver. Excess iron produces reactive oxygen species that induce inflammation, fibrosis, and cause ferroptosis, an iron-dependent form of
ASST_NON_R43DK133031_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchJune 16, 2022$255,236

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Chimerna Therapeutics, Inc. get?

$2.6 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Chimerna Therapeutics, Inc. the most?

The Department of Health and Human Services, with $2.6 million in 5 awards.

What is Chimerna Therapeutics, Inc.'s largest federal grant?

$1.5 million under Biomedical Research and Research Training, with its first action in the period on August 30, 2022. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Chimerna Therapeutics, Inc.?

Its largest are Biomedical Research and Research Training, National Center for Advancing Translational Sciences and Extramural Research Programs in the Neurosciences and Neurological Disorders.

Other grant recipients in New York

Largest federal grant recipients in New York · Federal grants in New York